What is Nuvation Bio Inc - Ordinary Shares - Class A Annual Net Profit?

Nuvation Bio Inc - Ordinary Shares - Class A Annual Net Profit fell 649.24% in the last year to $567.94 M. Its sector's average net profit growth for the last fiscal year was -13.88%.

What is Nuvation Bio Inc - Ordinary Shares - Class A Price to Earning Ratio?

Nuvation Bio Inc - Ordinary Shares - Class A Price to Earning Ratio is -1.37, which is negative.

What is Nuvation Bio Inc - Ordinary Shares - Class A Stock Price?

Nuvation Bio Inc - Ordinary Shares - Class A Stock Price fell 9.93% and underperformed its sector by 36.47% in the past year.

What is Nuvation Bio Inc - Ordinary Shares - Class A Quarterly Net profit?

Nuvation Bio Inc - Ordinary Shares - Class A Quarterly Net profit fell 259.9% YoY to $53.24 M. Its sector's average net profit growth YoY for the quarter was -238.37%.

What is Nuvation Bio Inc - Ordinary Shares - Class A Debt to Equity Ratio?

Nuvation Bio Inc - Ordinary Shares - Class A Debt to Equity Ratio of 0.02 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Nuvation Bio Inc - Ordinary Shares - Class A Return on Equity(ROE)?

Nuvation Bio Inc - Ordinary Shares - Class A Return on Equity(ROE) for the last financial year was -106.27%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Nuvation Bio Inc - Ordinary Shares - Class A Mutual Fund Holding?

Nuvation Bio Inc - Ordinary Shares - Class A Mutual Fund Holding decreased by 0.46% in the last quarter to 30.57.

What is Nuvation Bio Inc - Ordinary Shares - Class A Interest Coverage Ratio?

Nuvation Bio Inc - Ordinary Shares - Class A Interest Coverage Ratio is -1664.51, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Nuvation Bio Inc - Ordinary Shares - Class A Institutional Holding?

Nuvation Bio Inc - Ordinary Shares - Class A Institutional Holding increased by 3.41% in the last quarter to 62.16.

Nuvation Bio Inc - Ordinary Shares - Class A XNYS: NUVB

Nuvation Bio Inc - Ordinary Shares - Class A Live Share Price Today, Share Analysis and Chart

Name: Nuvation Bio Inc - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: Nuvation Bio Inc - Ordinary Shares - Class A
Rating: 1.59383325
Author: Trendlyne DVM scores

about

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-g...

2.45 0.11 (4.70%)

38.29% Fall from 52W High

4.4M XNYS Volume

XNYS 03 Jun, 2025 5:30 PM (EDT)

Not Eligible

-

Expensive Valuation

10.3 / 100

Technically Neutral

53.4 / 100

8

1Yr Price target upside is 220%

6 analysts

Nuvation Bio Inc - Ordinar... Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Nuvation Bio Inc - Ordinary Shares - Class A FAQ

How is Nuvation Bio Inc - Ordinary Shares - Class A today?

Nuvation Bio Inc - Ordinary Shares - Class A today is trading in the green, and is up by 4.70% at 2.45.

How has Nuvation Bio Inc - Ordinary Shares - Class A performed historically?

Nuvation Bio Inc - Ordinary Shares - Class A is currently trading up 4.70% on an intraday basis. In the past week the stock rose 9.38%. stock has been up 34.62% in the past quarter and fell -9.93% in the past year. You can view this in the overview section.